Abstract 14045: Pulmonary Hypertension Phenotype and Incretin-Based Therapy in CardioMEMS-Guided Heart Failure Management
In CardioMEMS-guided HF management, IBT use was independently associated with lower 2-year all-cause mortality after adjustment for PH phenotype and propensity score matching, and these findings support further prospective investigation of incretin-based therapies in advanced HF populations.